“…2,7-9,11,12,17 Others have suggested comparable regimens could reduce costs. 2,8,12,13 Previous reported selection criteria for reduced postoperative monitoring were quite strict (eg age <65, small tumors, no comorbidity 13 ), whereas we chose to allow all supratentorial tumor cases to be admitted to the general neurosurgical ward, except when the surgeon or anesthesiologist judged otherwise based on expected duration of surgery, expected blood loss, comorbidities, and functional status. Even though selection might be more subjective this way, more patients can be included in the new regimen, which we have shown is safe; therefore, we do not see a need for more stringent criteria for ICU/MCU admission postcraniotomy.…”